Neostem lands key patent in Japan

|By:, SA News Editor

Neostem (NBS +0.9%) says it earned expanded IP protection in Japan for a T-regulatory cell program with a new grant.

The company says the patent will help it grow the reach of its Treg program internationally and accelerate the time to market for cardiovascular disease medicines in Japan.